Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Melanie K Greifer & James F Markowitz. (2006) Update in the treatment of paediatric ulcerative colitis. Expert Opinion on Pharmacotherapy 7:14, pages 1907-1918.
Read now
Read now
Articles from other publishers (21)
Gian Marco Leone, Katia Mangano, Maria Cristina Petralia, Ferdinando Nicoletti & Paolo Fagone. (2023) Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy. Journal of Clinical Medicine 12:4, pages 1630.
Crossref
Crossref
Yoko Yokoyama, Kenji Watanabe, Hiroaki Ito, Masakazu Nishishita, Koji Sawada, Yusuke Okuyama, Kazuichi Okazaki, Hisao Fujii, Hiroshi Nakase, Tsutomu Masuda, Ken Fukunaga, Akira Andoh & Shiro Nakamura. (2015) Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study. Cytotherapy 17:5, pages 680-688.
Crossref
Crossref
Melissa I. Chang, Benjamin L. Cohen & Alexander J. Greenstein. (2015) A Review of the Impact of Biologics on Surgical Complications in Crohnʼs Disease. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
Adrian Reuben. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease
569
591
.
Dario Sorrentino, Giovanni Terrosu, Alberto Paviotti, Marco Geraci, Claudio Avellini, Giorgio Zoli, Walter Fries, Silvio Danese, Pietro Occhipinti, Tiziano Croatto & Dimitra Zarifi. (2012) Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab—A Pilot Study. Digestive Diseases and Sciences 57:5, pages 1341-1348.
Crossref
Crossref
Shaun McKenzie & B. Mark Evers. 2012. Sabiston Textbook of Surgery. Sabiston Textbook of Surgery
1227
1278
.
Giampaolo Talamo & Maurizio Zangari. 2012. HCV Infection and Cryoglobulinemia. HCV Infection and Cryoglobulinemia
349
355
.
Dario Sorrentino, Alberto Paviotti, Giovanni Terrosu, Claudio Avellini, Marco Geraci & Dimitra Zarifi. (2010) Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease. Clinical Gastroenterology and Hepatology 8:7, pages 591-599.e1.
Crossref
Crossref
Kay Johswich, Myriam Martin, André BleichProf.Prof., Michael KrachtProf.Prof., Oliver Dittrich-Breiholz, Engelbert J. GessnerProf.Prof., Sebastian SuerbaumProf.Prof., Elisabeth Wende, Claudia RheinheimerProf.Prof. & Andreas KlosProf.Prof.. (2009) Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease. Inflammatory Bowel Diseases 15:12, pages 1812-1823.
Crossref
Crossref
Kweku A. Appau, Victor W. Fazio, Bo Shen, James M. Church, Bret Lashner, Feza Remzi, Aaron Brzezinski, Scott A. Strong, Jeffrey Hammel & Ravi P. Kiran. (2008) Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients. Journal of Gastrointestinal Surgery 12:10, pages 1738-1744.
Crossref
Crossref
V. S. THEIS & J. M. RHODES. (2007) Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 27:1, pages 19-30.
Crossref
Crossref
J. Markowitz. (2008) Current treatment of inflammatory bowel disease in children. Digestive and Liver Disease 40:1, pages 16-21.
Crossref
Crossref
Yasuyuki Ishizuka, Sawako Moriwaki, Miyuki Kawahara-Hanaoka, Yasunori Uemura, Isao Serizawa, Mutsumi Miyauchi, Shunichi Shibata, Toshimichi Kanaya, Takashi Takata, Naoyuki Taniguchi & Shumpei Niida. (2007) Treatment With Anti-γ-Glutamyl Transpeptidase Antibody Attenuates Osteolysis in Collagen-Induced Arthritis Mice. Journal of Bone and Mineral Research 22:12, pages 1933-1942.
Crossref
Crossref
Nicolas Larmonier, Dominique Cathelin, Claire Larmonier, Alexandra Nicolas, Delphine Merino, Nona Janikashvili, Sylvain Audia, Andrew Bateman, Jill Thompson, Tim Kottke, Thomas Hartung, Emmanuel Katsanis, Richard Vile & Bernard Bonnotte. (2007) The inhibition of TNF-α anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Experimental Cell Research 313:11, pages 2345-2355.
Crossref
Crossref
Ulrich Klotz, Alexander Teml & Matthias Schwab. (2007) Clinical Pharmacokinetics and Use??of??Infliximab. Clinical Pharmacokinetics 46:8, pages 645-660.
Crossref
Crossref
D AMRE, RD AMRE & S PRAKASH. 2007. Artificial Cells, Cell Engineering and Therapy. Artificial Cells, Cell Engineering and Therapy
454
468
.
E. J. Irvine. 2007. Emerging Issues in Inflammatory Bowel Diseases. Emerging Issues in Inflammatory Bowel Diseases
181
188
.
Heather A. Behanna, D. Martin Watterson & Hantamalala Ralay Ranaivo. (2006) Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: A lead compound that attenuates vascular leak. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1763:11, pages 1266-1274.
Crossref
Crossref
William A. FaubionJrJr & Athos Bousvaros. (2006) Medical Therapy for Refractory Pediatric Crohn’s Disease. Clinical Gastroenterology and Hepatology 4:10, pages 1199-1213.
Crossref
Crossref
Gary R. Lichtenstein, Russell Cohen, Beverly Yamashita & Robert H. Diamond. (2006) Quality of Life After Proctocolectomy With Ileoanal Anastomosis for Patients With Ulcerative Colitis. Journal of Clinical Gastroenterology 40:8, pages 669-677.
Crossref
Crossref
Vladimir Vexler & Jacky Woo. (2006) Antibody treatment of ulcerative colitis. Drug Discovery Today: Therapeutic Strategies 3:3, pages 353-360.
Crossref
Crossref